Skip to main content

258 results

Sort by

Sort order

Filter by Date

Updated after
For example, 28 2 2024
Updated before
For example, 13 12 2025

Filter by Topic

Filter by Type

Type
  • A proactive, collaborative, agile and the first of its kind approach to identifying and addressing the challenges faced by AI as a Medical Device (AIaMD).

  • Apply now to join the AI Airlock pilot by the MHRA. Benefit from industry and regulatory expert collaboration, bespoke testing plans, and improved regulatory understanding.

  • Phase 2 of the Airlock will include seven additional technologies spanning AI-powered clinical note taking, advanced cancer diagnostics, eye disease detection tools, and obesity treatment support systems.

  • The call for applications for phase 2 of the AI Airlock is now closed.

  • An overview of the five technologies selected for the AI Airlock pilot.

  • Background information for MHRA AI Airlock launched in Spring 2024 and is the MHRA’s first regulatory sandbox for AI as a Medical Device (AIaMD) products.

  • Key insights of three simulation workshops from the AI Airlock pilot testing programme. Please note that these documents are not formal guidance.

  • The MHRA’s AI Airlock pilot phase ran between April 2024 and March 2025. This report does not constitute formal MHRA guidance.